Back
Sierra Bancorp 10K Form
Buy
70
BSRR
Sierra Bancorp
Last Price:
$36.89
Seasonality Move:
-0.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-06 | 10Q | BSRR/Sierra Bancorp Quarterly |
| 2024-03-25 | 10K | BSRR/Sierra Bancorp Annual |
| 2024-03-22 | 10K | BSRR/Sierra Bancorp Annual |
| 2023-11-02 | 10Q | BSRR/Sierra Bancorp Quarterly |
| 2023-08-03 | 10Q | BSRR/Sierra Bancorp Quarterly |
| 2023-05-05 | 10Q | BSRR/Sierra Bancorp Quarterly |
Receive BSRR News And Ratings
See the #1 stock for the next 7 days that we like better than BSRR
BSRR Financial Statistics
Sales & Book Value
| Annual Sales: | $200.4M |
|---|---|
| Cash Flow: | $14.7M |
| Price / Cash Flow: | 19.14 |
| Annual Sales: | $27.49 |
| Price / Book: | 1.37 |
Profitability
| EPS (TTM): | 3.12370 |
|---|---|
| Net Income (TTM): | $42.3M |
| Gross Margin: | $0 |
| Return on Equity: | 11.83% |
| Return on Assets: | 1.14% |
Sierra Bancorp Earnings Forecast
Key Sierra Bancorp Financial Ratios
-
The Gross Profit Margin over the past 27 years for BSRR is 0.00%.
-
The Selling, General & Administrative Expenses for BSRR have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 20.96% of Operating Income.
-
The Net Earning history of BSRR is 20.24% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 18 years.
Sierra Bancorp Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Banks |
| Sector: | Financials |
| Current Symbol: | BSRR |
| CUSIP: | 82620P |
| Website: | sierrabancorp.q4ir.com |
Debt
| Debt-to-Equity Ratio: | 1.42 |
|---|---|
| Current Ratio: | 0.07 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.94 |
|---|---|
| Forward P/E Ratio: | 10 |
BSRR Technical Analysis vs Fundamental Analysis
Buy
70
Sierra Bancorp (BSRR)
is a Buy
Is Sierra Bancorp a Buy or a Sell?
-
Sierra Bancorp stock is rated a BuyThe current Sierra Bancorp [BSRR] share price is $37.13. The Score for BSRR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.